Pharmafile Logo
Pharmafocus logo
Advanced Search

vectura

Showing 10 posts of 10 posts found.

Vectura removed from DDL Conference amid PMI deal

September 21, 2021
Manufacturing and Production DDL, inhalers, pmi, vectura

 Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …

News
ward_lilley

Vectura CEO to step down at end of June

June 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura

Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …

News
stocks1

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

November 27, 2018
Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …

News
trevor-philips

Vectura’s COO set to step down

March 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …

Appointment
asthma_inhalers

Vectura asthma treatment fails at Phase III

August 30, 2016
Manufacturing and Production, Research and Development asthma, inhaler, phase III, phase III failure, vectura

Respiratory drug specialist Vectura’s asthma treatment Flutiform was unsuccessful in meeting the primary endpoint in its Phase III trial conducted …

News
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

News
Janssen image

J&J acquires Index Ventures-owned firm XO1

March 23, 2015
Sales and Marketing Index Ventures, Isis, J&J, JJ, Janssen, vectura, xo1

Johnson & Johnson’s pharma unit Janssen has acquired Index Ventures’ biopharma firm XO1 Limited that develops the promising anti-thrombin antibody …

News
Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

News

GSK breathes more easily after Sandoz exit

March 24, 2010
Sales and Marketing Advair, Sandoz, generics, vectura

Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …

News

Vectura buys Innovata

January 22, 2007
Research and Development biotech, vectura

 Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …

News

Latest content

Roche to acquire Carmot Therapeutics for $2.7bn

December 4, 2023

Eli Lilly’s Jaypirca approved in US for leukaemia and lymphoma treatment

December 4, 2023

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023